Eight Advisory advised Ypsomed AG on the sale of its pen needle and blood glucose monitoring business to MTD Medical Technology and Devices

Eight Advisory advised Ypsomed AG on the sale of its pen needle and blood glucose monitoring business to MTD Medical Technology and Devices

Eight Advisory provided financial and carve-out services to Ypsomed AG in support of the sale of its pen needle and blood glucose monitoring business to MTD Medical Technology and Devices S.p.A.

Ypsomed, a leading developer and manufacturer in the field of self-medication and diabetes care, has carved-out and sold its pen needle and blood glucose monitoring systems (BGMs) business to MTD. With a global network of production sites and more than 2,200 employees worldwide, Ypsomed is a preferred partner of pharmaceutical and biotech companies and a renowned diabetes specialist.

 

With this divestment, Ypsomed is focusing its diabetes care business even more strongly on the further development and marketing of the innovative mylife Loop insulin pump solution.

 

MTD is a global manufacturer of medical devices for self-care and professional use. The medical technology group has over 16.000 clients and continuously expands its product portfolio by collaborating with pharma companies and innovative start-ups.

 

 

Eight Advisory team members supporting on this transaction:

  • Financial Due Diligence: Patric Roth, Partner, Pál Blaskó, Senior Manager, Jan-Niklas Herden, Manager, and Gezim Gurgurovci, Analyst
  • Carve-out services: Curt-Oliver Luchtenberg, Partner, Aaron Krüttgen, Director, and Maximilian Künstner, Senior

Patric

Roth

Partner

Transaction Services

Eight Advisory Zurich

Curt-Oliver

Luchtenberg

Partner

Strategy & Operations

Eight Advisory Cologne

Your message has been sent
Thank you, your application has been sent.

Report request

Similar
Articles

Deals

Eight Advisory supported Evolem and Nord Access Group on the acquisition of Services Voltige

17 May 2024

Read more

Insights

CFO Stories with Eight Advisory

16 May 2024

Read more

Insights

CFO Strategies in the Era of Increasing Distressed Carve-Out Transactions -

15 May 2024

Read more

Deals

Eight Advisory supported Cap10 Partners on its acquisition of Compass Community

14 May 2024

Read more

All the news

Your message has been sent
Thank you, your application has been sent.

What is the subject of your request?

  • General questions
  • Jobs
  • Information for the press

Specify your request

Choose an office

  • Eight Advisory London

  • Eight Advisory Paris

  • Eight Advisory Rennes

  • Eight Advisory Nantes

  • Eight Advisory Lyon

  • Eight Advisory Marseille

  • Eight Advisory Brussels

  • Eight Advisory Frankfurt

  • Eight Advisory Munich

  • Eight Advisory Hamburg

  • Eight Advisory Zurich

  • Eight Advisory Amsterdam

  • Eight Advisory Cologne

  • Eight Advisory Madrid

  • Eight Advisory New York

Application

Unsolicited application

Specify your request